Trial Holdings Inc. (141A) AI Stock Analysis

• Market Cap: ¥287.72B
• Dividend Yield: 0.68%
• Average Volume (3M): 2.25M
• Price to Earnings (P/E): 24.4
• Beta (1Y): 0.20
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: JP
• Employees: 6,529
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Discount Stores
• EPS (TTM): 27.62
• Shares Outstanding: 122,382,900
• 10 Day Avg. Volume: 943,710
• 30 Day Avg. Volume: 2,252,326
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥2,636.00
• Price Target Upside: 12.12% Upside
• Rating Consensus: Hold
• Number of Analyst Covering: 1

• Rating: 63 Neutral
• Price Target: ¥2,636.00 ▲(12.12% Upside)

The overall stock score is primarily influenced by financial performance, which shows strong revenue growth but highlights concerns in profitability and cash flow management. Technical analysis indicates a potential downtrend, while valuation suggests the stock may be overvalued. The absence of earnings call and corporate events data limits additional insights.

Trial Holdings Inc. Business Overview & Revenue Model

Company Description

Trial Holdings Inc. operates in the retail, logistics, financial / payment services, and retail tech businesses. The company operates discount-based stores that provide food, living ware, and home appliances. It also offers various solutions utilizing IoT devices, and software services. In addition, the company is involved in the real estate, restaurants, and resort businesses. The company was founded in 1974 and is based in Fukuoka, Japan.

How the Company Makes Money

Trial Holdings Inc. generates revenue through several key streams. Primarily, the company earns income from its clinical trial services, which include consulting fees for data management and patient recruitment. Additionally, Trial Holdings receives revenue from its investments in biotech firms, taking equity stakes in companies with promising drug candidates. These investments often yield returns through successful exits, either via public offerings or acquisitions. The company also benefits from strategic partnerships with pharmaceutical companies, which may involve joint ventures or collaborative projects that provide a share of profits from successful drug development.

Trial Holdings Inc. Financial Statement Overview

Summary

Trial Holdings Inc. shows strong revenue growth and operational efficiency, but profitability and cash flow management need improvement. The balance sheet remains robust, though increasing debt levels require attention. Overall, the company is on a stable trajectory but must address cash flow challenges to ensure long-term financial health.

Income Statement

Trial Holdings Inc. has demonstrated consistent revenue growth over the years, with a recent growth rate of 2.96%. The gross profit margin has improved to 20.78%, indicating efficient cost management. However, the net profit margin remains relatively low at 1.46%, suggesting room for improvement in profitability. The EBIT and EBITDA margins are stable, reflecting operational efficiency.

Balance Sheet

The company's debt-to-equity ratio has increased to 0.31, indicating a moderate level of leverage. Return on equity is strong at 9.32%, showcasing effective use of shareholder funds. The equity ratio stands at 42.00%, suggesting a solid capital structure. However, the increase in total debt warrants careful monitoring.

Cash Flow

The cash flow situation is concerning, with negative operating and free cash flows in the latest period. The free cash flow growth rate is negative, indicating cash flow challenges. The operating cash flow to net income ratio is negative, highlighting potential liquidity issues. Improvement in cash flow management is necessary.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	783.41B	806.59B	720.44B	655.48B	597.69B	157.93B
Gross Profit	158.78B	167.60B	144.84B	117.53B	103.49B	26.32B
EBITDA	30.34B	33.74B	30.78B	25.03B	21.58B	5.42B
Net Income	10.32B	11.75B	11.44B	8.08B	7.13B	1.85B
Balance Sheet
Total Assets	271.07B	300.28B	283.63B	200.64B	185.73B	171.44B
Cash, Cash Equivalents and Short-Term Investments	47.56B	72.33B	91.95B	23.90B	27.43B	22.74B
Total Debt	12.85B	38.58B	16.14B	19.61B	24.44B	27.94B
Total Liabilities	145.57B	171.25B	165.44B	132.62B	126.02B	118.65B
Stockholders Equity	122.67B	126.13B	115.68B	65.89B	57.96B	51.47B
Cash Flow
Free Cash Flow	0.00	-38.41B	36.84B	1.70B	9.39B	-7.14B
Operating Cash Flow	0.00	-4.45B	59.50B	18.45B	22.34B	-2.94B
Investing Cash Flow	0.00	-35.89B	-26.00B	-16.77B	-13.49B	-4.72B
Financing Cash Flow	0.00	20.77B	34.50B	-5.19B	-4.32B	-1.34B

Trial Holdings Inc. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2351.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:141A, the sentiment is Negative. The current price of 2351 is below the 20-day moving average (MA) of 2543.45, below the 50-day MA of 2498.90, and below the 200-day MA of 2415.72, indicating a bearish trend. The MACD of -30.96 indicates Positive momentum. The RSI at 39.60 is Neutral, neither overbought nor oversold. The STOCH value of 9.25 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:141A.

Trial Holdings Inc. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
7646	74 Outperform	12.68B	39.28	2.54%	4.54%	-1.53%	48.90%
7451	68 Neutral	274.28B	11.47	10.63%	2.94%	1.49%	6.34%
3080	67 Neutral	9.07B	38.41	5.49%	1.84%	-2.46%	-58.62%
8203	66 Neutral	28.65B	10.31	6.87%	2.67%	6.32%	10.30%
141A	63 Neutral	¥287.72B	24.43	―	0.68%	―	―
2264	63 Neutral	316.50B	42.49	2.05%	2.52%	2.97%	-46.46%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%

Trial Holdings Inc. Corporate Events

TRIAL Holdings Reports Mixed Sales Amid Weather Challenges and Strategic Growth

TRIAL Holdings, Inc. reported fluctuations in sales and customer traffic, with a notable increase in average spending. Despite challenges from high comparative figures from the previous year and temporary store closures due to extreme weather, the company managed to maintain solid performance in fresh and ready meals, particularly during the Obon season. Non-food items showed mixed results, with declines in some categories but strong sales in summer apparel and bedding. The company continues to expand its store network with new openings and renovations.

The most recent analyst rating on (JP:141A) stock is a Buy with a Yen3166.00 price target. To see the full list of analyst forecasts on Trial Holdings Inc. stock, see the JP:141A Stock Forecast page.

TRIAL Holdings Reports 12% Sales Growth Amidst Liquidity Concerns

TRIAL Holdings, Inc. reported a 12% increase in net sales for the fiscal year ending June 30, 2025, reaching ¥803,829 million. Despite the growth in sales, the company’s profit attributable to owners rose modestly by 2.7% to ¥11,752 million. The company’s financial position showed improvement with an equity-to-asset ratio of 42% and net assets per share increasing to ¥1,031.30. However, cash flows from operating activities were negative at ¥4,446 million, indicating potential liquidity challenges. The company announced a slight increase in annual dividends per share from ¥15.00 to ¥16.00, reflecting a commitment to returning value to shareholders.

Trial Holdings Inc. Reports Strong Sales Growth and Strategic Expansion

Trial Holdings Inc. reported a steady increase in sales and average spending, despite a decline in customer traffic due to strategic gross profit growth initiatives. The company experienced strong demand for fresh and ready meals, particularly during the hot summer months, which contributed to the growth in same-store sales for 50 consecutive months. The company also expanded its footprint with five new store openings and no closures, while planning to disclose SEIYU’s sales growth data starting July 2026.

Trial Holdings Inc. Reports Steady Growth and Expansion

Trial Holdings Inc. reported a steady growth in sales and customer traffic, with notable performance in both food and non-food categories. The company expanded its store network with four new openings and no closures in June. Despite weather challenges and fewer holidays affecting sales slightly, the company maintained a robust market position with strong sales in seasonal products and ready meals.

TRIAL Holdings Completes Acquisition of Seiyu Co., Ltd.

TRIAL Holdings, Inc. has successfully completed the acquisition of Seiyu Co., Ltd., making it a wholly owned subsidiary as of July 1, 2025. This acquisition marks a significant expansion for TRIAL Holdings, as Seiyu operates a retail chain selling groceries, apparel, and household goods. The consolidation of Seiyu into TRIAL’s financial statements will begin in the fiscal year ending June 2026, with earnings forecasts to be disclosed later, indicating a strategic move to strengthen its market position.

TRIAL Holdings Secures Loan for Seiyu Acquisition

TRIAL Holdings, Inc. has announced the execution of a loan agreement with financial covenants to fund the acquisition of Seiyu Co., Ltd., making it a wholly owned subsidiary. The loan, amounting to 367.4 billion yen from MUFG Bank, Ltd., is unsecured and scheduled for a one-year repayment. This strategic acquisition is expected to enhance TRIAL Holdings’ market positioning, although the financial impact will be reflected in the fiscal period ending June 2026.

Trial Holdings Inc. Reports Continued Sales Growth and Store Expansion

Trial Holdings Inc. reported a consistent increase in sales and customer traffic, with a notable 48-month streak of same-store sales growth. The company has been expanding its store count, opening three new locations in May while closing one. The introduction of measures to improve gross profit has positively impacted customer traffic and average spending, indicating a strong operational performance. Favorable weather conditions during the first half of Golden Week contributed to increased sales in non-food categories such as DIY tools and home appliances.